The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency
Milano, 17 Febbraio 2023. Molteni Farmaceutici, azienda di riferimento a livello europeo nello sviluppo e produzione di farmaci analgesici-oppioidi per la terapia del dolore e il trattamento delle tossicodipendenze, insieme agli imprenditori delle FAB13, le tredici aziende italiane medio-grandi del farmaco aderenti a Farmindustria, ha partecipato all’incontro con il Ministro delle Imprese e del Made in Italy, Adolfo Urso.
Prezzi, meccanismi di gara e fabbisogni le leve su cui agire secondo la coalizione delle industrie impegnate nella risposta alla crisi globale della resistenza antimicrobica
DALIAN, China, Feb. 16, 2023 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") officially launched China's first methanol-to-hydrogen and hydrogen refueling service station (the "Service Station") in Dalian, China yesterday. An upgrade from the previous fueling station offering oil, gas, hydrogen, electric charging services, the integrated complex can produce 1,000 kilograms of hydrogen a day, with a purity of 99.999 percent.
The EMBRACE Registry aims to evaluate safety and performance of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis when used as a bridging stent with branched and fenestrated endografts in the treatment of aortic aneurysms involving the renal-mesenteric arteries.
--As part of China’s second booster campaign, Clover’s premium, broadly protective protein-based vaccine is now available in Zhejiang province with additional provinces and municipalities to follow in Q1 2023--
--As part of China’s second booster campaign, Clover’s premium, broadly protective protein-based vaccine is now available in Zhejiang province with additional provinces and municipalities to follow in Q1 2023--
Il partenariato e la commessa a Steriline
- Storage and Transport Offered in Two Temperature Ranges, Following East Japan Pharmaceutical Center -
Dragonfly now wholly owns the IL12 cytokine, currently in mid-Phase 1 dose escalation as a monotherapy and in combination with nivolumab. Dragonfly's IL12 was designed to combine well with a broad range of oncology agents including radiation, chemo, PD1s and Dragonfly's proprietary NK cell engaging drug candidates including its HER2-targeting TriNKET in Phase 2 and EGFR-targeting TriNKET in Phase 1.
Platform reduces friction across the eConsent, IRT, and eCOA user experience for sponsors, CROs, sites and patients.
ROTTERDAM, Paesi Bassi e HOUSTON, 2 febbraio 2023 /PRNewswire/ -- LyondellBasell ha annunciato oggi di aver firmato i primi due accordi europei di compravendita di energia elettrica da fonti rinnovabili (PPA) e altri due accordi negli Stati Uniti. I contratti combinati apporteranno una fornitura totale di circa 560 megawatt (MW) di energia rinnovabile. LyondellBasell ha sottoscritto otto accordi PPA e raggiunto oltre la metà del suo obiettivo per il 2030 di ricavare almeno il 50% dell'elettricità...
BEIJING, Jan. 30, 2023 /PRNewswire/ -- Help Therapeutics Co., Ltd. (hereinafter Help Therapeutics) has revealed that the China Center for Drug Evaluation (CDE) has approved the investigational new drug (IND) application of HiCM-188, a human (allogeneic) iPS cell-derived cardiomyocyte therapy in patients with worsening ischemic heart failure.
SEOUL, South Korea, Jan. 26, 2023 /PRNewswire/ -- GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, announced that it has entered into a strategic research collaboration with a US-based biopharma company for the development of in vivo gene editing therapies. This collaboration will utilize GenKOre's proprietary CRISPR-Cas platform, TaRGET (Tiny nuclease, augment RNA-based Genome Editing Technology). The TaRGET platform is distinct from the most popular genome editin...
CO.DON continues business operations as a GmbH (limited liability company)
DOWNERS GROVE, Illinois, Stati Uniti, 23 gennaio 2023 /PRNewswire/ -- Univar Solutions Inc (NYSE: UNVR) ("Univar Solutions" o "la Società"), fornitore leader mondiale di soluzioni per gli utenti di ingredienti e prodotti chimici speciali, ha annunciato oggi di aver firmato un accordo per l'acquisizione del distributore turco leader di prodotti chimici speciali Kale Kimya.
Pemion® affirms itself as a viable and advantageous option to conventional per-fluorinated materials
TOKYO, Jan. 18, 2023 /PRNewswire/ -- A Belgian economic mission visited the West Japan Pharmaceutical Center in Neyagawa, Osaka Prefecture, of Nippon Express Co., Ltd. (hereinafter "Nippon Express"), which is a group company of NIPPON EXPRESS HOLDINGS, INC., on Friday, December 9.
CHENGDU, China, Jan. 18, 2023 /PRNewswire/ -- Keymed Biosciences Inc. (Stock Code: 02162 HK) is pleased to announce that the latest data from the Phase Ia dose-escalation trial of CMG901 (Claudin 18.2 antibody drug conjugate), a novel drug candidate, for advanced solid tumors will be presented as a poster at the 2023 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (2023 ASCO GI).
La sicurezza ambientale è un fattore cruciale per le imprese produttive e attraverso analisi puntuali e precise possono essere drasticamente ridotti i rischi di incidenti.
